Takeda announced five new partnerships to its Global Corporate Social Responsibility, CSR, Program, which contribute to strengthening health systems in low- and middle-income countries. The new partnerships bring its total contributions to JPY 24.2 billion across 29 long-term partnerships. Takeda’s commitments to these new partners in FY2023 include: JPY 834 million to Society for Family Health, Rwanda to expand access to quality healthcare in remote and hard-to-reach communities in Rwanda. JPY 1,146 million to Relief International to improve access to essential medicines and medical supplies in communities devastated by conflict, climate change and disaster in Afghanistan, Yemen, Myanmar and Syria. JPY 1,048 million to Mercy Corps to help climate-fragile communities save lives, improve health, and build climate resiliency for over 3 million people. JPY 671 millionto Partners In Health to elevate and equip 3,000 nurses and midwives in Haiti, Mexico, Peru, Lesotho, Liberia, Malawi, Rwanda and Sierra Leone. JPY 793 million to University of Nairobi to create a pioneering, public health-focused machine learning and data science training program to strengthen the leadership pipeline and impact of women to improve health in their communities.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on TAK:
- Takeda reports ‘positive’ results from Phase 2b study evaluating TAK-279
- Takeda price target lowered to $14 from $14.20 at JPMorgan
- ImmunoGen (NASDAQ:IMGN): Bio Powerhouse Moving into Japan
- ImmunoGen announces collaboration with Takeda for ELAHERE
- Denali Therapeutics price target lowered to $31 from $37 at Wedbush